| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000233237.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001030797 |
Resistant |
| ENSG00000233237.2 |
Axitinib |
Brain lower grade glioma |
0.043294244 |
Resistant |
| ENSG00000233237.2 |
Axitinib |
Head and neck squamous cell carcinoma |
0.028407878 |
Sensitive |
| ENSG00000233237.2 |
Axitinib |
Lung squamous cell carcinoma |
0.043136202 |
Sensitive |
